How and when will we know that a COVID-19 vaccine is safe and effective?

Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?

William Petri, Professor of Medicine, University of Virginia • conversation
Sept. 22, 2020 ~10 min

Tags: covid-19 immune-system pandemic fda vaccines sars-cov-2 phase-3-trial immune-response vaccine-trials covid-19-vaccine vaccine-safety vaccine-approval

Will the new 15-minute COVID-19 test solve US testing problems?

The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Sept. 1, 2020 ~6 min

Tags: covid-19 coronavirus fda screening sars-cov-2 food-and-drug-administration testing viruses abbott emergency-use-authorization antigen-test pcr-testing covid-test

FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines

The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?

Yaniv Heled, Associate Professor of Law, Georgia State University • conversation
Aug. 27, 2020 ~10 min

Tags: covid-19 fda coronavirus-2020 covid-19-vaccine convalescent-plasma

A potential new weapon in the fight against COVID-19: Food coloring

Aerosols of some FDA-approved food coloring could deactivate airborne viruses.

Yuhyun Ji, Doctoral student in Biomedical Engineering, Purdue University • conversation
Aug. 20, 2020 ~4 min

Tags: covid-19 coronavirus pandemic fda sars-cov-2 viruses infection aerosols disinfection disinfectant pathogen airborne-transmission virus-transmission

Oleandrin is a deadly plant poison, not a COVID-19 cure

Consuming the plant can be lethal to animals and humans.

Cassandra Quave, Assistant Professor of Dermatology and Human Health; Herbarium Curator, Emory University • conversation
Aug. 18, 2020 ~3 min

Tags: covid-19 coronavirus pandemic plants fda medicinal-plants

Rapid screening tests that prioritize speed over accuracy could be key to ending the coronavirus pandemic

Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.

Zoë McLaren, Associate Professor of Public Policy, University of Maryland, Baltimore County • conversation
Aug. 14, 2020 ~9 min

Tags: covid-19 coronavirus fda sars-cov-2 food-and-drug-administration testing viruses false-positive rt-pcr swab-test false-negative diagnostic-test

Could pressure for COVID-19 drugs lead the FDA to lower its standards?

The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?

Leigh Turner, Associate Professor, University of Minnesota Center for Bioethics, School of Public Health, & College of Pharmacy, University of Minnesota • conversation
June 10, 2020 ~10 min

Tags:  covid-19  coronavirus  pandemic  donald-trump  fda  food-and-drug-administration  hydroxychloroquine  clinical-trials  oversight

A Lyme disease vaccine doesn't exist, but a yearly antibody shot shows promise at preventing infection

Researchers are developing a seasonal shot that blocks Lyme disease-causing bacteria from a tick.

Mark Klempner, Professor of Medicine and Executive Vice Chancellor for MassBiologics, University of Massachusetts Medical School • conversation
June 4, 2020 ~7 min

Tags: mice fda vaccines lyme-disease prevention

From the research lab to your doctor's office – here's what happens in phase 1, 2, 3 drug trials

Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.

Mindy Aisen, Clinical Professor of Neurology, University of Southern California • conversation
June 2, 2020 ~8 min

Tags: covid-19 coronavirus pandemic fda viruses clinical-trials placebo randomized-clinical-trial rct evidence-based-medicine

What needs to go right to get a coronavirus vaccine in 12-18 months

Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.

Marcos E. García-Ojeda, Professor of Molecular and Cell Biology, University of California, Merced • conversation
May 8, 2020 ~10 min

Tags: dna health coronavirus immune-system rna fda vaccines sars-cov-2 food-and-drug-administration immune-response coronavirus-vaccine immune clinical-trials

Page 1 of 2